These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29256835)

  • 1. Implication of Formulation Strategies on the Bioavailability of Selected Plant-Derived Hepatoprotectants.
    Dash RP; Kala M; Nivsarkar M; Babu RJ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(6):489-526. PubMed ID: 29256835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads.
    Negi AS; Kumar JK; Luqman S; Shanker K; Gupta MM; Khanuja SP
    Med Res Rev; 2008 Sep; 28(5):746-72. PubMed ID: 17979145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in herbal medicine for treatment of liver diseases.
    Ghosh N; Ghosh R; Mandal V; Mandal SC
    Pharm Biol; 2011 Sep; 49(9):970-88. PubMed ID: 21595500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective properties of extensively studied medicinal plant active constituents: possible common mechanisms.
    Farghali H; Canová NK; Zakhari S
    Pharm Biol; 2015 Jun; 53(6):781-91. PubMed ID: 25489628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant and hepatoprotective effects of mixed micellar lipid formulation of phyllanthin and piperine in carbon tetrachloride-induced liver injury in rodents.
    Sethiya NK; Shah P; Rajpara A; Nagar PA; Mishra SH
    Food Funct; 2015 Nov; 6(11):3593-603. PubMed ID: 26333006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin.
    Girish C; Pradhan SC
    Fundam Clin Pharmacol; 2008 Dec; 22(6):623-32. PubMed ID: 19049667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing bioavailability of silymarin.
    Javed S; Kohli K; Ali M
    Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past and present scenario of hepatoprotectants.
    Ram VJ; Goel A
    Curr Med Chem; 1999 Mar; 6(3):217-54. PubMed ID: 10219101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives.
    Domitrović R; Potočnjak I
    Arch Toxicol; 2016 Jan; 90(1):39-79. PubMed ID: 26377694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patented bioavailability enhancement techniques of silymarin.
    Javed S; Kohli K; Ali M
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):145-52. PubMed ID: 20156178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of bioactive compounds in Nymphaea alba L. leaves growing in Egypt: hepatoprotective, antioxidant and anti-inflammatory activity.
    Bakr RO; El-Naa MM; Zaghloul SS; Omar MM
    BMC Complement Altern Med; 2017 Jan; 17(1):52. PubMed ID: 28095910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Artichoke--herbal drug].
    Kulza M; Adamska K; Seńczuk-Przybyłowska M; Woźniak A; Wachowiak A; Miechowicz I; Horoszkiewicz M; Nowak G; Florek E
    Przegl Lek; 2012; 69(10):1122-6. PubMed ID: 23421105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells.
    Hsiang CY; Lin LJ; Kao ST; Lo HY; Chou ST; Ho TY
    Phytomedicine; 2015 Jul; 22(7-8):768-77. PubMed ID: 26141764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective activity of Indian Phyllanthus.
    Srirama R; Deepak HB; Senthilkumar U; Ravikanth G; Gurumurthy BR; Shivanna MB; Chandrasekaran CV; Agarwal A; Shaanker RU
    Pharm Biol; 2012 Aug; 50(8):948-53. PubMed ID: 22480277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in natural products from plants for treatment of liver diseases.
    Zhang A; Sun H; Wang X
    Eur J Med Chem; 2013 May; 63():570-7. PubMed ID: 23567947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hepatoprotective activity of Clerodendrum serratum L.
    Vidya SM; Krishna V; Manjunatha BK; Mankani KL; Ahmed M; Singh SD
    Indian J Exp Biol; 2007 Jun; 45(6):538-42. PubMed ID: 17585689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present status of hepatoprotectants.
    Ram VJ; Goel A
    Prog Drug Res; 1999; 52():53-101. PubMed ID: 10396126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers.
    Xie Y; Hao H; Kang A; Liang Y; Xie T; Sun S; Dai C; Zheng X; Xie L; Li J; Wang G
    J Ethnopharmacol; 2010 Sep; 131(2):290-9. PubMed ID: 20600750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a 43 kD hepatoprotective protein from the herb Cajanus indicus L.
    Sarkar K; Ghosh A; Kinter M; Mazumder B; Sil PC
    Protein J; 2006 Sep; 25(6):411-21. PubMed ID: 17091391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective studies on Hedyotis corymbosa (L.) Lam.
    Sadasivan S; Latha PG; Sasikumar JM; Rajashekaran S; Shyamal S; Shine VJ
    J Ethnopharmacol; 2006 Jun; 106(2):245-9. PubMed ID: 16495024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.